Standard Treatment Options for Monoclonal Gammopathy of Undetermined Significance (MGUS)
Standard treatment options for MGUS include the following:
Multiple myeloma, other plasma cell dyscrasia, or lymphoma will develop in 12% of patients by 10 years, 25% by 20 years, and 30% by 25 years.
All patients with MGUS should be kept under observation to detect increases in M protein levels and development of a plasma cell dyscrasia. Higher levels...
Fever, sweats, and hot flashes affect quality of life in many patients with cancer.
A treatment plan to help manage fever, sweats, or hot flashes is based on the patient's condition and goals of care. For some patients, relieving symptoms and improving quality of life is a more important goal than treating the fever to prolong life.
This summary describes the causes and treatment of fever, sweats, and hot flashes in cancer patients.